Inhibition of phospholipase D1 induces immunogenic cell death and potentiates cancer immunotherapy in colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2092-6413
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Inhibition of phospholipase D1 induces immunogenic cell death and potentiates cancer immunotherapy in colorectal cancer ; volume:54 ; number:9 ; day:21 ; month:9 ; year:2022 ; pages:1563-1576 ; date:9.2022
Experimental & molecular medicine ; 54, Heft 9 (21.9.2022), 1563-1576, 9.2022
- Creator
-
Hwang, Won Chan
Song, Doona
Lee, Hyesung
Oh, Changmok
Lim, Seong Hun
Bae, Hyeon Jeong
Kim, Nam Doo
Han, Gyoonhee
Min, Do Sik
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s12276-022-00853-6
- URN
-
urn:nbn:de:101:1-2022122221011852402590
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hwang, Won Chan
- Song, Doona
- Lee, Hyesung
- Oh, Changmok
- Lim, Seong Hun
- Bae, Hyeon Jeong
- Kim, Nam Doo
- Han, Gyoonhee
- Min, Do Sik
- SpringerLink (Online service)
Other Objects (12)
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
Endothelin Inhibition Potentiates Cancer Immunotherapy Revealing Mechanical Biomarkers Predictive of Response
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment
Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy
Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy
Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer
Multi‐Enzyme Nanoparticles as Efficient Pyroptosis and Immunogenic Cell Death Inducers for Cancer Immunotherapy
Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy
Identification of naturally presented immunogenic HLA ligands of prostate cancer and HCMV-infected cells for immunotherapy
Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
Endothelin Inhibition Potentiates Cancer Immunotherapy Revealing Mechanical Biomarkers Predictive of Response
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment
Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy
Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy
Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer
Multi‐Enzyme Nanoparticles as Efficient Pyroptosis and Immunogenic Cell Death Inducers for Cancer Immunotherapy
Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy
Identification of naturally presented immunogenic HLA ligands of prostate cancer and HCMV-infected cells for immunotherapy
Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Local Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
Endothelin Inhibition Potentiates Cancer Immunotherapy Revealing Mechanical Biomarkers Predictive of Response
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment
Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy
Metabolic Reprogramming of NK Cells by Black Phosphorus Quantum Dots Potentiates Cancer Immunotherapy
Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer
Multi‐Enzyme Nanoparticles as Efficient Pyroptosis and Immunogenic Cell Death Inducers for Cancer Immunotherapy
Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy
Identification of naturally presented immunogenic HLA ligands of prostate cancer and HCMV-infected cells for immunotherapy
Triple‐Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo‐Immunotherapy in Preclinical Cancer Models